Baseline prevalence of lung cancer screening and covariates among women undergoing breast cancer screening in Missouri. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting I. This ...
Modeling of pharmacodynamic (PD) biomarkers (BM) related to CDK4/6 inhibition and exploratory BM-response (progression free survival [PFS]) analyses in patients with advanced breast cancer. This is an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results